Autolus Therapeutics Ltd Market Cap ($404.57 Million)

$404.57 Million USD · Rank #13003

Market Cap & Net Worth: Autolus Therapeutics Ltd (AUTL)

Autolus Therapeutics Ltd market cap. Autolus Therapeutics Ltd (NASDAQ:AUTL) has a market capitalization of $404.57 Million ($404.57 Million) as of November 1, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #13003 globally and #3206 in its home market, demonstrating a -3.80% decrease in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying Autolus Therapeutics Ltd's stock price $1.52 by its total outstanding shares 266162540 (266.16 Million). Also see Autolus Therapeutics Ltd cash conversion from operations for how efficiently the company converts equity into cash flow.

Autolus Therapeutics Ltd Market Cap History (2018–2026)

Autolus Therapeutics Ltd market cap history from 2018 to 2026. Data shows change from $8.74 Billion to $404.57 Million (-28.46% CAGR). Check latest Autolus Therapeutics Ltd stock price today for real-time trading data and today's change.

Index Memberships

Autolus Therapeutics Ltd is a constituent of 3 market indices:

Index	Total Market Cap	Weight (%)	Rank by Market Cap
NASDAQ Health Care IXHC	$2.62 Trillion	0.02%	#355 of 976
NASDAQ Composite IXIC	$40.09 Trillion	0.00%	#1283 of 3165
NASDAQ Biotechnology NBI	$1.84 Trillion	0.02%	#196 of 263

Weight: Autolus Therapeutics Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.

Autolus Therapeutics Ltd Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how Autolus Therapeutics Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Autolus Therapeutics Ltd (AUTL) net asset momentum to track how rapidly the company is growing its equity base year over year.

Latest Price to Sales (P/S) Ratio

7.01x

Autolus Therapeutics Ltd's market cap is 7.01 times its annual revenue

Industry average: 3868.91x Lower than industry average

Latest Price to Earnings (P/E) Ratio

N/A

P/E ratio not applicable due to negative or zero earnings

What These Ratios Tell Investors:

Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
Industry comparison provides context for whether the company is valued higher or lower than peers.

Year	Market Cap (USD)	Revenue (USD)	Net Income (USD)	P/S Ratio	P/E Ratio
2018	$8.74 Billion	$1.05 Million	-$31.11 Million	8361.64x	N/A
2018	$8.74 Billion	$1.05 Million	-$31.11 Million	8361.64x	N/A
2019	$3.51 Billion	$2.91 Million	-$123.85 Million	1208.17x	N/A
2020	$2.38 Billion	$1.72 Million	-$142.09 Million	1387.46x	N/A
2021	$1.38 Billion	$1.51 Million	-$142.10 Million	916.64x	N/A
2022	$505.71 Million	$6.19 Million	-$148.84 Million	81.64x	N/A
2023	$1.71 Billion	$1.70 Million	-$208.38 Million	1009.47x	N/A
2024	$625.48 Million	$10.12 Million	-$220.66 Million	61.81x	N/A
2025	$529.66 Million	$75.56 Million	-$288.20 Million	7.01x	N/A

Competitor Companies of AUTL by Market Capitalization

Companies near Autolus Therapeutics Ltd in the global market cap rankings as of November 1, 2026. Also see Autolus Therapeutics Ltd total assets for a full breakdown of the balance sheet.

Key companies related to Autolus Therapeutics Ltd by market ranking:

Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #182 globally with a market cap of $130.90 Billion USD.
Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #371 globally with a market cap of $76.14 Billion USD.
CSL Ltd (AU:CSL): Ranked #412 globally with a market cap of $68.91 Billion USD ( AU$97.38 Billion AUD).
Moderna Inc (NASDAQ:MRNA): Ranked #495 globally with a market cap of $54.14 Billion USD.

Market capitalization comparison (in billions USD)

Rank	Company	Symbol	Market Cap	Price
#182	Vertex Pharmaceuticals Inc	NASDAQ:VRTX	$130.90 Billion	$558.88
#371	Regeneron Pharmaceuticals Inc	NASDAQ:REGN	$76.14 Billion	$927.89
#412	CSL Ltd	AU:CSL	$68.91 Billion	AU$200.73
#495	Moderna Inc	NASDAQ:MRNA	$54.14 Billion	$221.72

Market Capitalization of Autolus Therapeutics Ltd (2018–2026)

Market capitalization of Autolus Therapeutics Ltd from 2018 to today. Between 2018 and today, Autolus Therapeutics Ltd's market cap moved from $8.74 Billion to $ 404.57 Million, with a yearly change of -28.46%.

Year	Market Cap	Change (%)
2026	$404.57 Million	-23.62%
2025	$529.66 Million	-15.32%
2024	$625.48 Million	-63.51%
2023	$1.71 Billion	+238.95%
2022	$505.71 Million	-63.39%
2021	$1.38 Billion	-41.95%
2020	$2.38 Billion	-32.27%
2019	$3.51 Billion	-59.81%
2018	$8.74 Billion	--

End of Day Market Cap According to Different Sources

On Oct 31st, 2026 the market cap of Autolus Therapeutics Ltd was reported to be:

Source	Market Cap
Yahoo Finance	$404.57 Million USD
MoneyControl	$404.57 Million USD
MarketWatch	$404.57 Million USD
marketcap.company	$404.57 Million USD
Reuters	$404.57 Million USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.

About Autolus Therapeutics Ltd

NASDAQ:AUTL USA Biotechnology

Market Cap

$404.57 Million

Market Cap Rank

#13003 Global

#3206 in USA

Share Price

$1.52

Change (1 day)

-3.80%

52-Week Range

$1.21 - $2.54

All Time High

$48.01